Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitris Rizopoulos

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
Journal of Affective Disorders|July 17, 2025
Do young people get the mental healthcare they need? Trajectories of depressive symptoms, correlates and care pathways in a clinical sample of young people reaching the upper age limit of their CAMHSLarissa S van Bodegom, Suzanne E Gerritsen, Athanasios Maras, et al.
Blood|August 27, 2013
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALLArian van der Veer, Esmé Waanders, Rob Pieters, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2024
Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's diseaseStephanie A Vuijk, Maria M E Jongsma, Britt M Hoeven, et al.
Circulation. Cardiovascular Interventions|July 13, 2021
Endovascular Revascularization Plus Supervised Exercise Versus Supervised Exercise Only for Intermittent Claudication: A Cost-Effectiveness AnalysisFarzin Fakhry, Ellen V Rouwet, Reinier Spillenaar Bilgen, et al.
Annals of Surgery|December 30, 2020
Long-term Follow-up of a Randomized Clinical Trial Comparing Endovascular Revascularization Plus Supervised Exercise With Supervised Exercise Only for Intermittent ClaudicationSanne Klaphake, Farzin Fakhry, Ellen V Rouwet, et al.
Gut|January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trialMaria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
JAMA|November 9, 2015
Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical TrialFarzin Fakhry, Sandra Spronk, Lijckle van der Laan, et al.
Critical Care (London, England)|March 27, 2026
Clinical correlates for major bleeding during veno-arterial extracorporeal membrane oxygenation support: a time-dependent perspectiveLara C A Pladet, Hassnae Boubrik, Kim Luijken, et al.
Journal of Affective Disorders|January 9, 2023
The importance of clinicians' and parents' awareness of suicidal behaviour in adolescents reaching the upper age limit of their mental health services in EuropeLarissa S van Bodegom, Suzanne E Gerritsen, Gwendolyn C Dieleman, et al.
Depression and Anxiety|April 14, 2025
Transition from Child and Adolescent to Adult Mental Health Services in Young People with Depression: On What Do Clinicians Base their Recommendation?Larissa S van Bodegom, Mathilde M Overbeek, Suzanne E Gerritsen, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
Journal of Affective Disorders|July 17, 2025
Do young people get the mental healthcare they need? Trajectories of depressive symptoms, correlates and care pathways in a clinical sample of young people reaching the upper age limit of their CAMHSLarissa S van Bodegom, Suzanne E Gerritsen, Athanasios Maras, et al.
Blood|August 27, 2013
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALLArian van der Veer, Esmé Waanders, Rob Pieters, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2024
Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's diseaseStephanie A Vuijk, Maria M E Jongsma, Britt M Hoeven, et al.
Circulation. Cardiovascular Interventions|July 13, 2021
Endovascular Revascularization Plus Supervised Exercise Versus Supervised Exercise Only for Intermittent Claudication: A Cost-Effectiveness AnalysisFarzin Fakhry, Ellen V Rouwet, Reinier Spillenaar Bilgen, et al.
Annals of Surgery|December 30, 2020
Long-term Follow-up of a Randomized Clinical Trial Comparing Endovascular Revascularization Plus Supervised Exercise With Supervised Exercise Only for Intermittent ClaudicationSanne Klaphake, Farzin Fakhry, Ellen V Rouwet, et al.
Gut|January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trialMaria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
JAMA|November 9, 2015
Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical TrialFarzin Fakhry, Sandra Spronk, Lijckle van der Laan, et al.
Critical Care (London, England)|March 27, 2026
Clinical correlates for major bleeding during veno-arterial extracorporeal membrane oxygenation support: a time-dependent perspectiveLara C A Pladet, Hassnae Boubrik, Kim Luijken, et al.
Journal of Affective Disorders|January 9, 2023
The importance of clinicians' and parents' awareness of suicidal behaviour in adolescents reaching the upper age limit of their mental health services in EuropeLarissa S van Bodegom, Suzanne E Gerritsen, Gwendolyn C Dieleman, et al.
Depression and Anxiety|April 14, 2025
Transition from Child and Adolescent to Adult Mental Health Services in Young People with Depression: On What Do Clinicians Base their Recommendation?Larissa S van Bodegom, Mathilde M Overbeek, Suzanne E Gerritsen, et al.
Pageof 23